🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested
Background: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-09-10
Trial ID
NCT07113743
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
This is an open-label, extension, Phase III study to evaluate the long-term...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00144625
Treatments Being Tested
randomized controlled trial comparing survival benefit of Tocilizumab thera...
Status
Completed
Location
Qena faculty medicine
Start Date
2020-03-01
Trial ID
NCT04519385
Treatments Being Tested
Tocilizumab concentrations above 1 mg/L are likely to be sufficient for nor...
Status
Unknown
Location
Reade Rheumatology Research Institute
Start Date
2020-03-01
Trial ID
NCT03895879
Treatments Being Tested
This observational trial will evaluate the effectiveness, the consistency o...
Status
Completed
Location
ASZ Aalst
Start Date
2015-10-31
Trial ID
NCT02552940
Treatments Being Tested
The host response against the coronavirus 2 (SARS-CoV-2) appears to be medi...
Status
Suspended
Location
Hospital La Milagrosa, GenesisCare
Start Date
2020-04-21
Trial ID
NCT04394182
This is a phase II open label trial designed to evaluate the efficacy of Ta...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2014-12
Trial ID
NCT02206035
Treatments Being Tested
To evaluate clinical efficacy and tolerability of MRA, patients with RA are...
Status
Completed
Location
Multiple Locations
Start Date
2003-03
Trial ID
NCT00144508
Treatments Being Tested